Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Full Supreme Court to hear challenge to Judicial Selection Committee law - 2Remote Headphones: Improve Your Sound Insight
- 3The Response to Self-improvement: Embracing a Development Outlook
- 4A coup too far: Why Benin's rebel soldiers failed where others in the region succeeded
- 5Grammy nominations 2026: Full list of nominees in every major category, including Album of the Year and Best New Artist
- Manual for Tracking down One of a kind Store Inns
- Netanyahu on Gush Etzion terror attack: 'We will complete war on all fronts'
- The Most Moving TED Talks You Want to Watch
- The Best Cell phone Brands for Tech Aficionados
- New movies to watch this weekend: See 'Wake Up Dead Man: A Knives Out Mystery' in theaters, rent 'Bugonia,' stream 'Caught Stealing' on Netflix
- Top 10 Moving Style Architects of the Year
- The Best Web-based Courses for Ability Advancement
- Consume Fat Quick: 10 Demonstrated Activities for Ideal Outcomes
- ‘Nahariya get ready’: Banner displaying Hezbollah threat mounted in Tehran’s Palestine Square
